Furthermore, segregation of NHL cell lines into BCL2High (t(14;18)+ and/or high BCL2 CN) and BCL2Low groups identifies the former group as being particularly sensitive to venetoclax.20 Here we have characterized additional NHL cell lines for sensitivity to venetoclax and navitoclax as well as their CN and/or t(14;18) translocation status (Supplementary Table 1). The gene discussed is BCL2; the disease is non-Hodgkin lymphoma.